183537-54-4 Usage
Organic compound
Yes
It is an organic compound as it contains carbon and hydrogen atoms, along with other elements.
Heterocyclic ring
Present
The compound contains a heterocyclic ring, which is a ring of atoms with at least one atom not being carbon.
Amino group
Present
The compound has an amino group (-NH2), which is a functional group consisting of a nitrogen atom bonded to two hydrogen atoms.
Synonyms
4-Amino-alpha-methyl-1,2,5-oxadiazole-3-methanol 2-oxide
These are alternative names for the same chemical compound.
Physical state
White crystalline solid
The compound appears as a white crystalline solid at room temperature.
Molecular weight
130.104 g/mol
This is the mass of one mole of the compound, which is the sum of the atomic weights of all the atoms in the molecule.
Pharmaceutical research and synthesis
Used in
The compound is utilized in pharmaceutical research and synthesis due to its potential biological activities.
Applications
Medicinal chemistry and drug discovery
It may have applications in the field of medicinal chemistry and drug discovery due to its structural properties and potential pharmacological properties.
Biological activities
Potential
The compound has potential biological activities, which could be explored for therapeutic purposes.
Check Digit Verification of cas no
The CAS Registry Mumber 183537-54-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,3,5,3 and 7 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 183537-54:
(8*1)+(7*8)+(6*3)+(5*5)+(4*3)+(3*7)+(2*5)+(1*4)=154
154 % 10 = 4
So 183537-54-4 is a valid CAS Registry Number.
183537-54-4Relevant articles and documents
α-Hydroxyalkyl(benzyl)furazans and α-hydroxyalkyl(benzyl)furoxans synthesis and reactivity
Blinnikov,Kulikov,Makhova,Khmel'nitskii
, p. 1692 - 1698 (2007/10/03)
A general and simple preparative method for the synthesis of α-hydroxyalkyl(benzyl)furazan and -furoxan derivatives is proposed. The method involves reduction of acyl or ethoxycarbonyl substituents in these heterocyclic compounds with NaBH4 in